Enbrel's new biosimilar recently got the green light it needed to treat several inflammatory health conditions.

The US Food and Drug Administration (FDA) has approved a new medication to treat multiple chronic inflammatory diseases.

The US Food and Drug Administration (FDA) has approved another biosimilar. This one is meant to treat multiple conditions that affect the immune system.

The US Food and Drug Administration has approved its fourth biosimilar.

The US Food and Drug Administration (FDA) has approved the first biosimilar etanercept. 

Generic versions of often expensive brand-name biologic medications appear safe and effective on the whole, a new study found.

The US Food and Drug Administration (FDA) has approved the second-ever biosimilar, and it's meant to treat multiple conditions that affect the immune system.

Antibiotics are miracle drugs that have saved millions of lives, but some worry that their overuse could have serious consequences. Now there may be yet another cause for concern.

Clinicians are generally familiar with the side effects of most prescribed medications. However, the safety of newer medications such as golimumab, an anti-TNF drug to treat autoimmune disorders, is still being examined.

Many people are living with more than one chronic disease. According to a recent study, many newly diagnosed arthritis patients may be living with another chronic disease.